Search Results 1111-1120 of 13326 for monoclonal antibody

  1. Mayo Clinic COVID-19 experts and focus areas Updated Dec. 3, 2021

    • Topics: COVID-19 therapeutics, including monoclonal antibody cocktail; inpatient treatment for COVID-19. • Dr. Badley video example: "Vaccines amid the ...

  2. Efficacy And Safety Of Tislelizumab In Combination With Fruquintinib In Participants With Selected Solid Tumors - Mayo Clinic

    ... monoclonal antibodies. Patients must not have received prior treatment with a VEGFR tyrosine kinase inhibitor. Except for Cohort D (MSS mCRC), patients must ...

  3. Oncology (Medical) - Clinical trials

    The purpose of this study is to assess the feasibility and develop procedures for detecting monoclonal proteins via finger pick blood spots and saliva. Data ...

  4. Study To Evaluate Safety And Tolerability Of XmAb13676 In Patients With CD20-expressing Hematologic Malignancies - Mayo Clinic

    Known intolerance to CD20 monoclonal antibody therapy. History of primary central nervous system lymphoma or neoplastic central nervous system disease ...

  5. A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturation Antigen (BCMA)-Exposed Participants With Relapsed/Refractory Multiple Myeloma (CAMMA 2) - Mayo Clinic

    antibody (TDB) antibody including non BCMA targeting TDB - Prior use of any monoclonal antibody (mAb), radioimmunoconjugate, or ADC as anti-cancer therapy ...

  6. Mayo Clinic Alzheimer's Disease Research Center Archives

    ... monoclonal antibody, lecanemab shows promise in removing amyloid plaques from the brain. Plaques are one of the defining features of Alzheimer's disease. Dr ...

  7. Ulcerative colitis - Diagnosis and treatment - Mayo Clinic

    Monoclonal antibody risankizumab for ulcerative colitis. JAMA. 2024; doi:10.1001/jama.2024.8819. Managing flares and IBD symptoms. Crohn's and Colitis ...

  8. Nonmelanoma Skin Cancer Clinical Trials - Mayo Clinic Research

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  9. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

    ... monoclonal antibody therapy; Palliative radiation therapy is permitted if clinically indicated and not indicative of progressive disease. Participating Mayo ...

  10. Safety And Efficacy Of ALLO-605 An Anti-BCMA Allogeneic CAR T Cell Therapy In Patients With Relapsed/Refractory Multiple Myeloma - Mayo Clinic

    Prior treatment with anti-CD52 monoclonal antibody (ALLO-647 is permitted). On-going treatment with immunosuppressive agents: Corticosteroid use within 1 ...